November 11, 2024
Fresenius opens Helios HSK Wiesbaden, one of the most modern hospitals in Germany
- Investment in the future of healthcare in the Rhine-Main region and beyond
- Helios HSK as an example of medical excellence and high-quality results throughout the entire patient journey
- Boris Rhein: "strong signal of the innovative power of Hessian companies and the strength of our economy"
Fresenius is continuing to develop its Care Provision Platform, of which Helios Germany is a core part: with the recently completed construction of Helios HSK’s new building in Wiesbaden, the company has opened one of Germany's most modern hospitals. Helios HSK is the core of the Wiesbaden-Taunus hospital cluster and is home to 25 specialist clinics and five institutes. At a launch ceremony today, around 400 guests from the worlds of politics, business and medicine paid tribute to the new building. In addition to the Prime Minister of the State of Hesse, Boris Rhein, dignitaries included the Hessian Minister of Health Diana Stolz, and Wiesbaden's Lord Mayor Gert-Uwe Mende.
Boris Rhein, Prime Minister of the State of Hesse: "All the employees of Helios HSK have done a great job of moving to the new clinic building while maintaining ongoing operations. Under challenging conditions, they have impressively demonstrated that patients are in the best of hands here. With this new building, our state capital has gained a maximum-care clinic and the most modern large hospital in Germany, featuring 25 specialist clinics, five institutes, and almost 900 beds. This also sends a strong signal of the innovative power of Hessian companies and the strength of our economy. With the opening ceremony, we are beginning a new chapter in healthcare in Hesse. On behalf of the Hessian state government, I would like to thank everyone involved and wish Helios HSK continued success."
Michael Sen, Fresenius CEO: "The new Helios HSK is a maximum care provider, delivering cutting-edge diagnostics and therapies using the latest technologies. Every day, our colleagues work tirelessly for patient wellbeing, embodying Fresenius’ promise: 'Committed to Life'. Medical progress is advancing more rapidly than at any time in history. From Artificial Intelligence, robotics and digital technologies to breakthroughs in genetic and cell research: today, therapies of a quality once unimaginable are now a reality. As a leading therapy-focused company, our mission is to make these advances available to as many people as possible, as quickly as possible."
Robert Möller, Member of the Fresenius Management Board and Helios CEO: "Top-notch medical care, high-quality treatment outcomes, and patient satisfaction are key to our success. Building a hospital from the ground up allowed us to design it with the latest medical and nursing knowledge, focusing entirely on patient needs. This has been achieved brilliantly here in Wiesbaden. My heartfelt thanks go to all the employees who brought this mammoth project to life. This new clinic will have a great impact beyond Wiesbaden and stands as one of the most modern medical workplaces in Germany."
Diana Stolz, Hessian Minister for Family Affairs, Senior Citizens, Sports, Health and Care: "As the Hessian Minister for Family Affairs and Health, I would like to draw particular attention to the fact that this new building has established the most modern care facilities for maternity, pediatric, and adolescent medicine. Now, all essential services – including obstetrics, neonatology, pediatric intensive care, and the children's hospital – are integrated under one roof and in close proximity. With this new building, we have empowered HSK, as a maximum-care provider, to keep pace with rapid medical advancements, to treat complex illnesses and injuries, to adapt its medical operations to these advances and changes, and to optimize its organization and operational procedures. Our guiding principle remains to deliver high-quality patient care across Hesse."
Investment in patient-centered care and state-of-the-art equipment
At Helios HSK, optimal treatment paths, the latest therapies and equipment with state-of-the-art medical technology enable cutting-edge medicine at a new level of treatment. Patients are welcomed into a hospital designed entirely around their needs from the ground up. Employees benefit from an attractive, state-of-the-art work environment that enables them to focus even more on patient care.
Among other things, Helios HSK is certified as an oncology center with ten certified organ centers and as a supra-regional trauma center. Around 170,000 patients per year can be treated in the seven-storey building with around 900 beds and around 3,000 employees.
The clinic's highlights include 22 surgery rooms, most of which have natural daylight, two intensive care units, a helicopter roof landing pad, a special stroke ward and an emergency room with access to cutting-edge technology. These include a special spectral computer tomograph supported by Artificial Intelligence. Only a few meters separate the arrival hall for ambulances from the shock room and other life-saving areas.
An entire wing of the hospital also houses a modern parent-child center with six delivery rooms, an intensive care unit for premature babies, and its own emergency surgery room. Short distances here too: everything is on one level and all experts for the care of the youngest children work together within easy reach.
The new Helios HSK building marks Fresenius' largest hospital investment project to date. The company financed the majority of the over 300 million euro investment from its own funds, with the state of Hesse contributing around 68 million euros.
This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, the availability of financing and unforeseen impacts of international conflicts. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.